-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$9.001630.77% Upside
Elevation Oncology, Inc. Frequently Asked Questions
-
What analysts cover Elevation Oncology, Inc.?
Elevation Oncology, Inc. has been rated by research analysts at Piper Sandler, Stephens in the past 90 days.